Nojima, H.; Yamamoto, M.; Kamada, J.; Hamanaka, T.; Aoyagi, K.
Fully Automated Measurement of GFAP in CSF Using the LUMIPULSE® System: Implications for Alzheimer’s Disease Diagnosis and Staging. Int. J. Mol. Sci. 2025, 26, 8134.
https://doi.org/10.3390/ijms26178134
AMA Style
Nojima H, Yamamoto M, Kamada J, Hamanaka T, Aoyagi K.
Fully Automated Measurement of GFAP in CSF Using the LUMIPULSE® System: Implications for Alzheimer’s Disease Diagnosis and Staging. International Journal of Molecular Sciences. 2025; 26(17):8134.
https://doi.org/10.3390/ijms26178134
Chicago/Turabian Style
Nojima, Hisashi, Mai Yamamoto, Jo Kamada, Tomohiro Hamanaka, and Katsumi Aoyagi.
2025. "Fully Automated Measurement of GFAP in CSF Using the LUMIPULSE® System: Implications for Alzheimer’s Disease Diagnosis and Staging" International Journal of Molecular Sciences 26, no. 17: 8134.
https://doi.org/10.3390/ijms26178134
APA Style
Nojima, H., Yamamoto, M., Kamada, J., Hamanaka, T., & Aoyagi, K.
(2025). Fully Automated Measurement of GFAP in CSF Using the LUMIPULSE® System: Implications for Alzheimer’s Disease Diagnosis and Staging. International Journal of Molecular Sciences, 26(17), 8134.
https://doi.org/10.3390/ijms26178134